Výsledky vyhledávání - "F V, Fossella"

Adenocarcinoma of the lung in young patients: the M. D. Anderson experience

Autor: N S, Liu, M R, Spitz, B L, Kemp, C, Cooksley, F V, Fossella, J S, Lee, W K, Hong, F R, Khuri

Publikováno v: Cancer. 88(8)

Surveillance, Epidemiology, and End Results (SEER) data for the years 1973-1992 documented that patients age50 years presented with more advanced disease. Because of the increase in the incidence rate of lung adenocarcinoma in the past few decades an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::92980b29e92014961efa960c6faaf260
https://pubmed.ncbi.nlm.nih.gov/10760760

Zobrazit plný text záznamu

Docetaxel in the treatment of non-small cell lung cancer: review of single-agent trials

Autor: F V, Fossella

Publikováno v: Seminars in oncology. 26(5 Suppl 16)

Several phase II studies have evaluated docetaxel, administered as a 1-hour intravenous infusion at a dose of 100 mg/m2 every 3 weeks, for chemotherapy-naive patients with advanced non-small cell lung cancer. Results have been consistent across numer

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::469781acdf839d7ba7fcd0620cb4849a
https://pubmed.ncbi.nlm.nih.gov/10585004

Zobrazit plný text záznamu

Overview of docetaxel (Taxotere) in the treatment of non-small cell lung cancer

Autor: F V, Fossella

Publikováno v: Seminars in oncology. 26(3 Suppl 11)

In four initial phase II studies of docetaxel administered as a 1-hour intravenous infusion at a dose of 100 mg/m2 every 3 weeks in chemotherapy-naive patients with advanced non-small cell lung cancer (NSCLC), the overall response rate was 31% in 128

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::aa56615a11f692cf76e9054f716b2d2a
https://pubmed.ncbi.nlm.nih.gov/10458203

Zobrazit plný text záznamu

The use of docetaxel (Taxotere) in patients with advanced non-small cell lung cancer previously treated with platinum-containing chemotherapy regimens

Autor: F V, Fossella, J, Rigas

Publikováno v: Seminars in oncology. 26(3 Suppl 11)

Several phase II studies have evaluated docetaxel (Taxotere; Rhône-Poulenc Rorer, Antony, France) at a dose of 100 mg/m2 administered as a 1-hour intravenous infusion every 3 weeks in the second-line treatment of non-small cell lung cancer (NSCLC).

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::5486aa94de739acbc982a12672f07d57
https://pubmed.ncbi.nlm.nih.gov/10458204

Zobrazit plný text záznamu

Gene therapy for non-small cell lung cancer: a preliminary report of a phase I trial of adenoviral p53 gene replacement

Autor: J A, Roth, S G, Swisher, J A, Merritt, D D, Lawrence, B L, Kemp, C H, Carrasco, A K, El-Naggar, F V, Fossella, B S, Glisson, W K, Hong, F R, Khurl, J M, Kurie, J C, Nesbitt, K, Pisters, J B, Putnam, D S, Schrump, D M, Shin, G L, Walsh

Publikováno v: Seminars in oncology. 25(3 Suppl 8)

The identification of genetic lesions that lead a normal cell to become malignant presents us with the opportunity of targeting those lesions as a means of therapy. Given the key role played by the tumor suppressor gene p53 in cell cycle regulation a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::f7fa4e397004ff6bf419b53eaf5210e5
https://pubmed.ncbi.nlm.nih.gov/9704675

Zobrazit plný text záznamu

Paclitaxel/carboplatin chemotherapy as primary treatment of brain metastases in non-small cell lung cancer: a preliminary report

Autor: J S, Lee, K M, Pisters, R, Komaki, B S, Glisson, F R, Khuri, R, Schea, F V, Fossella

Publikováno v: Seminars in oncology. 24(4 Suppl 12)

Chemotherapy has been rarely considered an important treatment modality for brain metastases. Based on the hypothesis that the lack of efficacy of chemotherapy, rather than the blood-brain barrier itself, may be the major hindrance to the successful

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::3dd04ab6c93fc41f85f889ac913e5638
https://pubmed.ncbi.nlm.nih.gov/9331122

Zobrazit plný text záznamu

Management strategies for recurrent non-small cell lung cancer

Autor: F V, Fossella, J S, Lee, W K, Hong

Publikováno v: Seminars in oncology. 24(4)

Because the benefit of first-line chemotherapy for non-small cell lung cancer (NSCLC) may be marginal, the use of chemotherapy in the second-line setting for the patient who has failed primary platinum-containing chemotherapy (PCC) is similarly debat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::782c12ee7cb52711d77f6ca45bf12d68
https://pubmed.ncbi.nlm.nih.gov/9280225

Zobrazit plný text záznamu

Dosimetry and toxicity of samarium-153-EDTMP administered for bone pain due to skeletal metastases

Autor: J E, Bayouth, D J, Macey, L P, Kasi, F V, Fossella

Publikováno v: Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 35(1)

Palliation of bone pain in patients with cancer metastatic to bone is being evaluated in several cancer centers by the administration of the bone-seeking phosphonate ethylenediaminetetramethylenephosphonic acid (EDTMP) chelated with the beta particle

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::bd79e1801f82df7068ba7182bbb651c5
https://pubmed.ncbi.nlm.nih.gov/7505819

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání